Zobrazeno 1 - 10
of 20
pro vyhledávání: '"DEVIN ABRAHAMI"'
Publikováno v:
Journal of General Internal Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a83ccdc4e8a42781b28cc1f48416bf0a
https://doi.org/10.1007/s11606-023-08193-5
https://doi.org/10.1007/s11606-023-08193-5
Autor:
Laurent Azoulay, Elisabetta Patorno, Sebastian Schneeweiss, Robert W. Platt, Lysanne Campeau, Oriana H.Y. Yu, Blanaid Hicks, Seanna Vine, Huimin Yin, Helen Tesfaye, Devin Abrahami
Objective: To determine whether sodium-glucose co-transporter 2 (SGLT2) inhibitors, compared with glucagon-like peptide-receptor agonists (GLP-1RAs) or dipeptidyl peptidase-4 (DPP4) inhibitors are associated with an increased risk of early bladder ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8719f0d5295affe61d83425d37bdaee2
https://doi.org/10.2337/figshare.21040987
https://doi.org/10.2337/figshare.21040987
Autor:
Mireille E. Schnitzer, Laurent Azoulay, Emily G. McDonald, Devin Abrahami, Alan N. Barkun, Samy Suissa
Publikováno v:
Gut. 71:111-118
ObjectiveTo determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs).DesignThe United Kingdom Clinical Practice Research Datalink was used to id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c461f06a66598dc07a607f18922d6a
https://doi.org/10.1136/gutjnl-2021-325096
https://doi.org/10.1136/gutjnl-2021-325096
Autor:
DEVIN ABRAHAMI, HELEN TESFAYE, HUI YIN, ORIANA HOI YUN YU, ROBERT W. PLATT, SEBASTIAN SCHNEEWEISS, ELISABETTA PATORNO, LAURENT AZOULAY
Publikováno v:
Diabetes. 71
SGLT2 inhibitors (SGLT2is) have been shown to reduce the risk of cardiovascular and mortality events in large cardiovascular outcome trials in patients with type 2 diabetes. However, their safety profile is controversial, with some trials reporting i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b032c61c5584115b4286a420aacbb90
https://doi.org/10.2337/db22-1146-p
https://doi.org/10.2337/db22-1146-p
Autor:
DEVIN ABRAHAMI, ELVIRA D'ANDREA, SEOYOUNG C. KIM, DEBORAH J. WEXLER, JULIE M. PAIK, ELISABETTA PATORNO
Publikováno v:
Diabetes. 71
SGLT2 inhibitors (SGLT2i) are increasingly prescribed to treat type 2 diabetes (T2D) given their cardiovascular benefits. However, SGLT2i are known to increase the risk of diabetic ketoacidosis (DKA) , a rare yet serious outcome. It remains unclear w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c35c3089c98626552d6349493a400c5
https://doi.org/10.2337/db22-1145-p
https://doi.org/10.2337/db22-1145-p
Publikováno v:
Seminars in Arthritis and Rheumatism. 51:211-218
Objective Randomized controlled trials of the effectiveness of statins on rheumatic disease outcomes have shown limited or no benefit. On the other hand, observational studies have reported remarkable effectiveness of statins at reducing mortality in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e35fbe7e77888a674c35c98e2176f1
https://doi.org/10.1016/j.semarthrit.2020.11.010
https://doi.org/10.1016/j.semarthrit.2020.11.010
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2020, 120 (10), pp.1384-1394. ⟨10.1055/s-0040-1714213⟩
Thrombosis and Haemostasis, Schattauer, 2020, 120 (10), pp.1384-1394. ⟨10.1055/s-0040-1714213⟩
Objective Existing evidence on the association between vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) and cancer is limited and contradictory. No observational studies have been conducted to simultaneously address the cancer safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f90efa336936de15bbcc755382295418
https://doi.org/10.1055/s-0040-1714213
https://doi.org/10.1055/s-0040-1714213
Autor:
Devin Abrahami, Richeek Pradhan, Hui Yin, Russell Yanofsky, Emily Gibson McDonald, Alain Bitton, Laurent Azoulay
Publikováno v:
Gut. :gutjnl-2022
ObjectiveTo determine whether the use of proton pump inhibitors (PPIs) compared with the use of histamine-2 receptor antagonists (H2RAs) is associated with an increased risk of inflammatory bowel disease (IBD).DesignPopulation-based cohort study desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aef821668f34d19058c5f3c511ca1802
https://doi.org/10.1136/gutjnl-2022-328866
https://doi.org/10.1136/gutjnl-2022-328866
Autor:
Devin Abrahami, Emily G. McDonald, Samy Suissa, Mireille E. Schnitzer, Laurent Azoulay, Alan N. Barkun
Publikováno v:
Gut. 71(1)
ObjectiveTo determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs).DesignUsing the UK Clinical Practice Research Datalink, we conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92bda16c13e70531dc9917a3ac226d8a
https://pubmed.ncbi.nlm.nih.gov/34836917
https://pubmed.ncbi.nlm.nih.gov/34836917
Autor:
Elodie Baumfeld Andre, Richeek Pradhan, Laurent Azoulay, Hui Yin, Devin Abrahami, Vaishali Sahasrabudhe, Oriana Hoi Yun Yu
Publikováno v:
Clinical pharmacology and therapeutics. 109(5)
The United States Food and Drug Administration is considering replacing cardiovascular outcome trials (CVOTs) of antidiabetic drugs with trials that better represent patients with type 2 diabetes. However, designing such representative trials require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a211aa47b068f569b43df8a821f02320
https://pubmed.ncbi.nlm.nih.gov/33615445
https://pubmed.ncbi.nlm.nih.gov/33615445